M&A Deal Summary

IDIA Capital Investissement and BNP Paribas Developpement Acquire Landanger

On June 11, 2024, corporate investor IDIA Capital Investissement and growth capital firm BNP Paribas Developpement acquired medical products company Landanger from Arkea Capital and 21 Invest

Acquisition Highlights
  • This is IDIA Capital Investissement’s 4th and BNP Paribas Developpement’s 1st transaction in the Medical Products sector.
  • This is IDIA Capital Investissement’s 104th and BNP Paribas Developpement’s 24th transaction in France.

M&A Deal Summary

Date 2024-06-11
Target Landanger
Sector Medical Products
Buyer(s) IDIA Capital Investissement
BNP Paribas Developpement
Sellers(s) Arkea Capital
21 Invest
Deal Type Recapitalization

Target

Landanger

Paris, France
Landanger manufactures and distributes surgical instruments for which it also offers maintenance services. Landanger was founded in 1947 and is based in Paris, France.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 2

Buyer

IDIA Capital Investissement

Paris, France

Investor Investor Investor Investor Investor


Category Corporate Investor
Founded 1980
PE ASSETS 2.9B EUR
Size Large
Type Sector Focused
DESCRIPTION

IDIA Capital is a long-term agroindustry investor. Specific areas of interest include sectors related to the food industry, wine, agriculture production, and forestry. IDIA typically provides growth capital and can commit €1 to €50 million per transaction. IDIA is a unit of Credit Agricole Group’s Private Equity & Finance Division. The Firm is based in Paris.


DEAL STATS #
Overall 106 of 114
Sector: Medical Products M&A 4 of 4
Type: Recapitalization M&A Deals 1 of 1
Country: France M&A 104 of 112
Year: 2024 M&A 3 of 9
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2024-05-01 Transarc

Dijon, France

Transarc provides transportation services in France. Transarc covers most segments of the passenger transport market by coach, in particular school transport, regular lines, individualized or on-demand transport, staff transport, tourism, etc. Transarc was founded in 1932 and is based in Dijon, France.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2024-06-18 Cafes Folliet

Chambery, France

Cafes Folliet is a French company specializing in the roasting and distribution of hot drinks for professionals in the catering and hotel industry (CHR). Cafes Folliet was founded in 1880 and is based in Chambery, France.

Buy -
DESCRIPTION

BNP Paribas Developpement is the growth-oriented development arm of financial services firm and bank BNP Paribas. BNP Paribas Developpement supports a range of lower middle-market companies and looks to invest in minority positions to support growth. BNP Paribas Developpement was formed in 1988 and is based in Paris, France.


DEAL STATS #
Overall 28 of 31
Sector: Medical Products M&A 1 of 1
Type: Recapitalization M&A Deals 1 of 1
Country: France M&A 24 of 27
Year: 2024 M&A 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2023-12-19 Kercia

Paris, France

Kercia develops and provides secure electronic voting software and solutions for a wide range of organizations, including businesses, public entities, and associations. The Company offers multichannel voting platforms enabling online, mobile, and paper-based participation. Kercia was founded in 2007 and is based in Paris, France.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2024-09-18 Marbour

Marseille, France

Marbour is an international group with two main business divisions food products and environmental services. The company operates in the European dry and ready-to-eat rice industry and also provides environmental solutions, including water treatment and the distribution of chemical products. Marbour was founded in 1987 and is based in Marseille, France.

Buy -

Seller(S) 2

SELLER

Arkea Capital

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 2011
PE ASSETS 1.3B EUR
Size Large
Type Sector Agnostic
DESCRIPTION

Arkéa Capital is the private equity investment arm of diversified financial services company Crédit Mutuel Arkéa. Arkéa Capital looks to make long-term investments in established, market leading companies. The Group does not have any sector preferences. Arkéa Capital does not have any sector preferences and is headquartered in Brest.


DEAL STATS #
Overall 12 of 16
Sector: Medical Products M&A 1 of 1
Type: Recapitalization M&A Deals 1 of 1
Country: France M&A 12 of 16
Year: 2024 M&A 2 of 5
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2024-05-21 QualiRetraite

Le Mans, France

QualiRetraite is an advice, assistance and administrative support in matters of retirement, preparation of retirement reports, retirement audit. QualiRetraite was founded in 2010 and is based in Le Mans, France.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2024-07-03 Elveflow

Paris, France

Elveflow develops a range of state-of-the-art microfluidic instruments, for all kinds of microfluidic applications. Our microfluidic systems can be used in many different fields, such as biology, chemistry, drug delivery, but also for cosmetics and food. Elveflow was founded in 2011 and is based in Paris, France.

Buy -
SELLER

21 Invest

Treviso, Italy

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1992
PE ASSETS 1.0B EUR
Size Large
Type Sector Agnostic
DESCRIPTION

21 Invest is a private equity firm that targets investments in growth-oriented, middle-market Italian, French, and Polish companies operating in a variety of industries. The Firm invests in French businesses through 21 Centrale Partners, Italian companies through 21 Partners SGR, and Polish companies through 21 Concordia. The Firm targets transactions requiring at least €10 million of capital typically in the form of development capital for growth companies, buyout capital for managers, or replacement capital for companies facing succession issues or needing shareholder liquidity. 21 Invest was founded in 1992 and is based in Treviso, Italy.


DEAL STATS #
Overall 44 of 45
Sector: Medical Products M&A 1 of 1
Type: Recapitalization M&A Deals 1 of 1
Country: France M&A 21 of 22
Year: 2024 M&A 2 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2024-02-06 Monevia

Bydgoszcz, Poland

Monevia is a provider of liquidity enhancement solutions for SMEs segment in Poland. Monevia purchases non-overdue invoices from small and micro-enterprises. The service is an alternative to factoring, rarely offered by other financial institutions to small and micro enterprises in Poland. Monevia is based in Bydgoszcz, Poland.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2024-10-11 Meribel Pharma Solutions

Entzheim, France

Meribel Pharma Solutions is a pharmaceutical contract development and manufacturing organization (CDMO). Meribel Pharma Solutions develops, manufactures, and packages drugs in various forms (solid, liquid…) on value-adding niches, specialized in small and medium-sized batches. Meribel Pharma Solutions was founded in 2001 and is based in Entzheim, France.

Sell -